Cargando…
Identification of immune landscape signatures associated with clinical and prognostic features of hepatocellular carcinoma
While cancer immunotherapy has been remarkably successful in some malignancies, some cancers derive limited benefit from current immunotherapies. Here, we combined immune landscape signatures with hepatocellular carcinoma clinical and prognostic features to classify them into distinct subtypes. The...
Autores principales: | Yan, Hongmei, Chen, Yuchuan, Wang, Kai, Yu, Lu, Huang, Xixin, Li, Qianyu, Xie, Yuwen, Lin, Jiayu, He, Yueyun, Yi, Xinyu, Wang, Yanzhi, Chen, Longhua, Ding, Yi, Li, Yiyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732284/ https://www.ncbi.nlm.nih.gov/pubmed/33049716 http://dx.doi.org/10.18632/aging.103977 |
Ejemplares similares
-
Alterations of the Gut Microbiome Composition and Lipid Metabolic Profile in Radiation Enteritis
por: Li, Yiyi, et al.
Publicado: (2020) -
Development and Verification of a Prostate Cancer Prognostic Signature Based on an Immunogenomic Landscape Analysis
por: Cheng, Hong, et al.
Publicado: (2021) -
The landscape of UBE2S in hepatocellular carcinoma: Prognostic significance, immuno-oncology feature and drug response
por: Qiu, Lipeng, et al.
Publicado: (2022) -
Development and validation of a novel cellular senescence-related prognostic signature for predicting the survival and immune landscape in hepatocellular carcinoma
por: Sun, Rui, et al.
Publicado: (2022) -
A novel prognostic mRNA/miRNA signature for esophageal cancer and its immune landscape in cancer progression
por: Zhao, Yue, et al.
Publicado: (2021)